The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirect Line Regulatory News (DLG)

Share Price Information for Direct Line (DLG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 210.40
Bid: 209.00
Ask: 209.60
Change: 9.80 (4.89%)
Spread: 0.60 (0.287%)
Open: 197.70
High: 210.60
Low: 197.70
Prev. Close: 200.60
DLG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re No Intention to Make an Offer

22 Mar 2024 18:22

RNS Number : 0480I
Ageas Insurance International NV
22 March 2024

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART), DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE UK CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE").

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION. FOR IMMEDIATE RELEASE.

22 March 2024

Ageas SA/NV announces no offer will be made for Direct Line Insurance Group plc

Ageas SA/NV ("Ageas") announces that, following the two recent attempts to engage with the Board of Directors of Direct Line Insurance Group plc ("Direct Line") in relation to the acquisition by Ageas of the entire issued and to be issued share capital of Direct Line, which were both rejected, it will not make an offer for Direct Line. As a result of this announcement, Ageas (and any persons acting in concert with it) will, except with the consent of the UK Panel on Takeovers and Mergers (the "Panel"), be bound by the restrictions contained in Rule 2.8 of the Code.

For the purposes of Rule 2.8 of the Code, Ageas (and any persons acting in concert with it) reserves the right to announce an offer or possible offer for Direct Line or make or participate in an offer or possible offer for Direct Line and/or take any other action otherwise precluded under Rule 2.8 of the Code within six months of the date of this announcement in the following circumstances described in Note 2 to Rule 2.8 of the Code: (i) with the agreement of the Board of Directors of Direct Line; (ii) if a third party (including another publicly identified potential offeror) announces a firm intention to make an offer for Direct Line; (iii) if Direct Line announces a Rule 9 waiver (see Note 1 in the notes on Dispensations from Rule 9) or a reverse takeover (as defined in the Code); or (iv) if the Panel determines there has been a material change of circumstances.

On 19 January 2024, Ageas provided the Board of Direct Line with an initial possible offer proposal (the "Initial Possible Offer") to acquire the entire issued and to be issued share capital of Direct Line. The terms of the Initial Possible Offer were improved on 9 March 2024 and set out in an announcement (the "Improved Possible Offer") on 13 March 2024. Ageas believes that the proposal, on these terms, would have created significant value for both groups of shareholders and other stakeholders.

Throughout the entire process, Ageas has always sought engagement with Direct Line's Board. Ageas regrets that it has not been able to work collaboratively together with the Board of Directors of Direct Line towards a recommended Firm Offer. Ageas was not able to identify additional elements based on publicly available information that would justify significant adjustments to the terms of its possible offer. Therefore, consistent with its financial discipline, Ageas has decided not to make a Firm Offer.

Ageas continues to believe in the underlying attractiveness and future opportunities of the UK personal lines sector and the role of Ageas UK in this market, underpinned by its successful turnaround over the last few years. Ageas UK will continue to execute its focused personal lines insurance strategy alongside its valued distribution partners.

Ageas remains focused on the execution of its strategy, as a group of local companies outperforming in their markets, benefitting from synergies within the Group. Ageas re-iterates its confidence to deliver on its stated Impact24 financial and operating targets thanks to the strong performance of its operating entities. The Group's solid foundations underpin our attractive dividend growth ambitions in line with our stated Impact24 ambitions and beyond this strategic cycle.

Hans De Cuyper, CEO of Ageas, said:

"We had hoped to reach agreement on a jointly recommended Firm Offer together with the Direct Line Board. However, I am convinced that given the circumstances we took the right decision not to make an offer, staying true to who we are and what we stand for in terms of maintaining a friendly approach and respecting our financial discipline. I sincerely want to thank our employees and advisors who delivered outstanding performance exploring this opportunity, and our investors for their continued trust in our company."

BofA Securities (Lead Financial Adviser to Ageas SA/NV) +44 (0) 20 7628 1000

Jonathan Alpert

Geoff Iles

Marcus Jackson

Benjamin Ries

Sid Rishi

Deutsche Bank AG (Financial Adviser to Ageas SA/NV) +44 (0) 20 7545 8000

Marie-Soazic Geffroy

Hubert Vannier

Derek Shakespeare

Inigo de Areilza

Charles Farquhar

FGS Global (PR Adviser to Ageas SA/NV) +44 (0) 20 7251 3801 / Ageas-UK@fgsglobal.com

James Leviton

Chris Sibbald

Linklaters LLP is acting as legal adviser to Ageas.

Merrill Lynch International ("BofA Merrill Lynch"), which is authorised by the UK Prudential Regulatory Authority and regulated by the UK Financial Conduct Authority and the UK Prudential Regulatory Authority, is acting exclusively for Ageas and for no one else in connection with the possible offer for Direct Line and will not be responsible to anyone other than Ageas for providing the protections afforded to its clients or for providing advice in relation to the matters referred to in this announcement.

Deutsche Bank AG is a stock corporation (Aktiengesellschaft) incorporated under the laws of the Federal Republic of Germany with its principal office in Frankfurt am Main. It is registered with the local district court (Amtsgericht) in Frankfurt am Main under No HRB 30000 and licensed to carry on banking business and to provide financial services. The London branch of Deutsche Bank AG is registered as a branch office in the register of companies for England and Wales at Companies House (branch registration number BR000005) with its registered branch office address and principal place of business at 21, Moorfields, London EC2Y 9DB. Deutsche Bank AG is subject to supervision by the European Central Bank (ECB), Sonnemannstrasse 22, 60314 Frankfurt am Main, Germany, and the German Federal Financial Supervisory Authority (Bundesanstalt für Finanzdienstleistungsaufsicht or BaFin), Graurheindorfer Strasse 108, 53117 Bonn and Marie-Curie-Strasse 24-28, 60439 Frankfurt am Main, Germany. With respect to activities undertaken in the United Kingdom, Deutsche Bank AG is authorised by the Prudential Regulation Authority. It is subject to regulation by the Financial Conduct Authority and limited regulation by the Prudential Regulation Authority. Details about the extent of Deutsche Bank AG's authorisation and regulation by the Prudential Regulation Authority are available from Deutsche Bank AG on request.

Deutsche Bank AG, acting through its London branch ("Deutsche Bank") is acting as a financial adviser to Ageas and no-one else in connection with the matters described in this announcement and will not be responsible to anyone other than Ageas for providing the protections afforded to clients of Deutsche Bank, nor for providing advice in connection with the subject matter of this announcement or any other matter referred to in this announcement.

Important information

A copy of this announcement will be made available (in English), subject to certain restrictions relating to persons resident in restricted jurisdictions, on Ageas' website at https://www.ageas.com/investors/webpage-related-ageass-possible-offer-direct-line by no later than noon (London time) on 25 March 2024. The content of this website is not incorporated into and does not form part of this announcement.

This announcement and the information within it is not intended to, and does not, constitute or form part of any offer, invitation or the solicitation of an offer to purchase or subscribe for, sell or otherwise dispose of, any securities whether pursuant to this announcement or otherwise, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law. In particular, this announcement is not an offer of securities for sale into the United States. No offer of securities shall be made in the United States absent registration under the Securities Act of 1933, as amended, or pursuant to an exemption from, or in a transaction not subject to, such registration requirements. No statement contained or referred to in this announcement is intended to be a profit forecast.

This announcement has been prepared in accordance with English law and information disclosed may not be the same as that which would have been prepared in accordance with the laws of jurisdictions outside England.

The release, publication or distribution of this announcement in jurisdictions outside the United Kingdom may be restricted by law and therefore persons into whose possession this announcement comes should inform themselves about, and observe, such restrictions. Any failure to comply with such restrictions may constitute a violation of the securities law of any such jurisdiction.

Ageas is a listed international insurance Group with a heritage spanning 200 years. It offers Retail and Business customers Life and Non-Life insurance products designed to suit their specific needs, today and tomorrow, and is also engaged in reinsurance activities. As one of Europe's larger insurance companies, Ageas concentrates its activities in Europe and Asia, which together make up the major part of the global insurance market. It operates successful insurance businesses in Belgium, the UK, Portugal, Türkiye, China, Malaysia, India, Thailand, Vietnam, Laos, Cambodia, Singapore, and the Philippines through a combination of wholly owned subsidiaries and long-term partnerships with strong financial institutions and key distributors. Ageas ranks among the market leaders in the countries in which it operates. It represents a staff force of about 50,000 people and reported annual inflows of more than EUR 17 billion in 2023.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
STRQKBBDFBKDFNB
Date   Source Headline
29th Feb 20243:20 pmRNSForm 8.3 - Direct Line Insurance Group Plc
29th Feb 20243:17 pmRNSForm 8.3 - Direct Line Insurance Group plc
29th Feb 20243:15 pmRNSForm 8.3 - Direct Line Insurance Group plc
29th Feb 20243:00 pmRNSForm 8.3 - Direct Line Insurance Group PLC
29th Feb 20242:45 pmRNSForm 8.3 - Direct Line Insurance Group Plc
29th Feb 20242:45 pmRNSForm 8.3 - Ageas NV
29th Feb 20242:41 pmRNSForm 8.3 - Direct Line Insurance Group PLC
29th Feb 20242:19 pmRNSForm 8.3 - [Ageas SA/NV]
29th Feb 20242:17 pmRNSForm 8.3 - [Direct Line Insurance Group plc]
29th Feb 20241:23 pmGNWMan Group PLC : Form 8.3 - Direct Line Insurance Group plc
29th Feb 202412:53 pmRNSForm 8.3 - Direct Line Insurance Group Plc
29th Feb 202412:43 pmRNSForm 8.3 - Direct Line Insurance Group plc
29th Feb 202412:25 pmRNSForm 8.3 - Direct Line Insurance Group plc
29th Feb 202412:21 pmRNSForm 8.3 - Direct Line Insurance Group PLC
29th Feb 202412:19 pmRNSForm 8.3 - AGEAS NV
29th Feb 202412:09 pmRNSForm 8.3 - Direct Line Insurance Group plc
29th Feb 202412:00 pmRNSDirector/PDMR Shareholding
29th Feb 202411:32 amRNS20240228_DIRECT LINE INSURANCE_8.5 EPT RI_UK_MLI
29th Feb 202411:31 amRNS20240228_DIRECT LINE INSU_8.5 EPT NON-RI_UK_BOFASE
29th Feb 202411:31 amRNSForm 8.5 (EPT/RI) - DIRECTLINE INSURANCE GROUP PL
29th Feb 202411:09 amPRNForm 8 (OPD) - Direct Line Insurance Group Plc
29th Feb 202411:05 amRNSForm 8.5 (EPT/RI)- Direct Line Insurance Group plc
29th Feb 202410:58 amPRNForm 8.3 - Direct Line Insurance Group plc
29th Feb 202410:35 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - Direct Line Insurance Group plc - Ordinary Shares
29th Feb 202410:25 amRNSForm 8.3 - Ageas SA/NV
29th Feb 202410:20 amRNSForm 8.3 - Direct Line Insurance Group PLC
29th Feb 20249:47 amRNSForm 8.5 (EPT/RI)
28th Feb 20243:12 pmRNSResponse to Statement by Ageas SA/NV
28th Feb 20242:30 pmRNSForm 8.3 - Ageas SA/NV
28th Feb 202412:18 pmRNSPossible offer for Direct Line Insurance Group Plc
9th Feb 20248:00 amRNSCEO joining & preliminary results dates
31st Jan 20244:36 pmRNSDirector/PDMR Shareholding
30th Jan 20246:15 pmRNSDirector/PDMR Shareholding
28th Dec 20231:00 pmRNSDirector/PDMR Shareholding
7th Dec 202310:30 amRNSDirectorate Change
5th Dec 20236:09 pmRNSHolding(s) in Company
28th Nov 20234:30 pmRNSDirector/PDMR Shareholding
7th Nov 20237:00 amRNSTrading Update for Q3 2023
30th Oct 20236:00 pmRNSDirector/PDMR Shareholding
19th Oct 20231:45 pmRNSDirectorate Change
19th Oct 202311:32 amRNSResult of General Meeting
3rd Oct 202312:45 pmRNSCircular and Notice of General Meeting
28th Sep 20233:00 pmRNSDirector/PDMR Shareholding
22nd Sep 202311:48 amRNSHolding(s) in Company
22nd Sep 202310:30 amRNSDirector Declaration
7th Sep 20237:00 amRNSSale of Brokered Commercial Insurance Business
7th Sep 20237:00 amRNSHalf-Year Report 2023
1st Sep 20237:00 amRNSStatement re past business review
31st Aug 20236:00 pmRNSDirectorate Change
30th Aug 20234:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.